International Myeloma Working Group immunotherapy committee consensus guidelines and recommendations for optimal use of T-cell-engaging bispecific antibodies in multiple myeloma

Step into the forefront of myeloma treatment with this latest publication from the International Myeloma Working Group immunotherapy committee. Discover the groundbreaking world of immunotherapy, where innovations like CAR T-cell therapy and bispecific antibodies are reshaping myeloma treatment. An expert panel provides exclusive insights and tailored recommendations, guiding the way to optimised patient care. Ready…

Details

‘Just one thing HCPs would change’: Myeloma UK take HCP voice to global stage

Myeloma UK’s Clinical Service Excellence Programme (CSEP) team revealed insights from their survey entitled ‘Just one thing HCPs would change’ at two international conferences last year.

The data was presented ICCN 2023 in Glasgow and at the 2023 IMS 20th annual meeting and exposition in Athens. Read more to find out the ‘one thing’ healthcare professionals would change to improve their clinical service.

Details

Diagnosis and management of smouldering myeloma: A British Society for Haematology Good Practice Paper

Explore the latest guidelines for Smouldering Myeloma care in the British Society for Haematology Good Practice Paper. Discover evidence-based recommendations, including clear patient support, tailored vaccination strategies, and more. For a comprehensive overview, access the full paper here.

 

Spinal metastases and metastatic spinal cord compression

This NICE guideline covers recognition, referral, investigation and management of spinal metastases and metastatic spinal cord compression (MSCC). It is also relevant for direct malignant infiltration of the spine and associated cord compression. It aims to improve early diagnosis and treatment to prevent neurological injury and improve prognosis.

Read the guideline here.